Pharmaceutical News Singapore eDevelopment subsidiary Global BioLife’s 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis February 1, 2019February 1, 2019 Singapore eDevelopment Ltd (SeD) is pleased to announce that its U.S. biomedical subsidiary Global BioLife Inc. has developed 3F Antimicrobial More